Product Information
LORAZEPAM 2 MG/ML ORAL CONCENT is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.6470 per ML under NDC 65162068784. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2 mg/mL
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162068784
Classification
Generic
Dosage Form
CONCENTRATE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA091383On Market Since
2/1/2010
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6470 per ML |
|---|---|
| All-time high | $0.8544 (Mar 12, 2014) |
| All-time low | $0.5070 (May 23, 2018) |
| 52-week high | $0.6756 |
| 52-week low | $0.5682 |
| Median price | $0.6243 |
| Average price | $0.6281 |
| Largest weekly change | +21.5% (May 17, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG/ML ORAL CONCENT?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG/ML ORAL CONCENT, manufactured by Amneal Pharmaceuticals LLC, is $0.6470 per ML (NDC 65162068784), effective Jun 24, 2026.
How has the price of LORAZEPAM 2 MG/ML ORAL CONCENT changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has declined 4.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG/ML ORAL CONCENT?
Since Nov 28, 2013, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has ranged from a low of $0.5070 (May 23, 2018) to a high of $0.8544 (Mar 12, 2014), with a median of $0.6243 per ML.
Are there cheaper alternatives to LORAZEPAM 2 MG/ML ORAL CONCENT?
6 NADAC-published products share the same active ingredient, strength, and dosage form as LORAZEPAM 2 MG/ML ORAL CONCENT, but none are currently priced below it.
Who manufactures LORAZEPAM 2 MG/ML ORAL CONCENT?
LORAZEPAM 2 MG/ML ORAL CONCENT (NDC 65162068784) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification